Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions

被引:55
作者
Haskell-Luevano, C
Lim, S
Yuan, W
Cone, RD
Hruby, VJ [1 ]
机构
[1] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA
[2] Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA
关键词
alpha-MSH; MTII; SHU9119; melanocortin antagonists; melanotropin;
D O I
10.1016/S0196-9781(99)00167-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The melanocortin system is involved in the regulation of several diverse physiological pathways, including energy homeostasis. Several synthetic peptide analogs have been designed, synthesized, and pharmacologically characterized at the mouse melanocortin receptor subtypes MC1R, MC3R, MC4R, and MC5R. These peptides incorporate modifications of the melanocortin core amino acids His-Phe-Arg-Trp by using the cyclic lactam templates of the lead structures MTII and SHU9119. Analogs containing DNal(2') at position 7 resulted in partial agonist and antagonistic activities at the mMC3R while possessing full antagonistic activities at the mMC4R. Recently, the melanocortin-5 receptor (MC5R) has been demonstrated to have a role in the regulation of exocrine gland function. This study has characterized the following analogs of SHU9119 that possess antagonist activity at the MC5R: Ac-Nle-c[Asp-(1-Me)His(6)-DNal(2')7-Arg-Trp-Lys]-NH2, pA(2) = 7.1; Ac-Nle-c[Asp-(1-Me)His(6)-DNal(2')(7)-Arg-Nal(2')(9)-Lys]-NH2, pA(2) = 7.2; and Ac-Nle-c[Asp-Trp(6)-DNal(2')(7)-Arg-Nal(2')(9)-Lys]-NH2, pA(2) = 6.6. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 46 条
[1]   IDENTIFICATION OF ANTAGONISTS FOR MELANOCORTIN MC(3), MC(4) AND MC(5) RECEPTORS [J].
ADAN, RAH ;
OOSTEROM, J ;
LUDVIGSDOTTIR, G ;
BRAKKEE, JH ;
BURBACH, JPH ;
GISPEN, WH .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (03) :331-337
[2]   POTENT AND PROLONGED ACTING CYCLIC LACTAM ANALOGS OF ALPHA-MELANOTROPIN - DESIGN BASED ON MOLECULAR-DYNAMICS [J].
ALOBEIDI, F ;
CASTRUCCI, AMD ;
HADLEY, ME ;
HRUBY, VJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (12) :2555-2561
[3]  
CASTRO B, 1975, TETRAHEDRON LETT, V14, P1219
[4]   ALPHA-MELANOTROPIN - THE MINIMAL ACTIVE SEQUENCE IN THE LIZARD SKIN BIOASSAY [J].
CASTRUCCI, AML ;
HADLEY, ME ;
SAWYER, TK ;
WILKES, BC ;
ALOBEIDI, F ;
STAPLES, DJ ;
DEVAUX, AE ;
DYM, O ;
HINTZ, MF ;
RIEHM, JP ;
RAO, KR ;
HRUBY, VJ .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1989, 73 (01) :157-163
[5]   A COLORIMETRIC ASSAY FOR MEASURING ACTIVATION OF G(S)-COUPLED AND G(Q)-COUPLED SIGNALING PATHWAYS [J].
CHEN, WB ;
SHIELDS, TS ;
STORK, PJS ;
CONE, RD .
ANALYTICAL BIOCHEMISTRY, 1995, 226 (02) :349-354
[6]   Exocrine gland dysfunction in MC5-R-deficient mice: Evidence for coordinated regulation of exocrine gland function by melanocortin peptides [J].
Chen, WB ;
Kelly, MA ;
OpitzAraya, X ;
Thomas, RE ;
Low, MJ ;
Cone, RD .
CELL, 1997, 91 (06) :789-798
[7]  
De Wied D, 1991, Methods Achiev Exp Pathol, V15, P167
[8]   MOLECULAR-CLONING, FUNCTIONAL EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF A MOUSE MELANOCORTIN RECEPTOR GENE [J].
DESARNAUD, F ;
LABBE, O ;
EGGERICKX, D ;
VASSART, G ;
PARMENTIER, M .
BIOCHEMICAL JOURNAL, 1994, 299 :367-373
[9]   NEUROPEPTIDES DERIVED FROM PRO-OPIOCORTIN - BEHAVIORAL, PHYSIOLOGICAL, AND NEUROCHEMICAL EFFECTS [J].
DEWIED, D ;
JOLLES, J .
PHYSIOLOGICAL REVIEWS, 1982, 62 (03) :976-1059
[10]   Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study [J].
Dorr, RT ;
Lines, R ;
Levine, N ;
Brooks, C ;
Xiang, L ;
Hruby, VJ ;
Hadley, ME .
LIFE SCIENCES, 1996, 58 (20) :1777-1784